benoit lhermitte
benoit lhermitte
Affiliation inconnue
Adresse e-mail validée de chru-strasbourg.fr
Titre
Citée par
Citée par
Année
Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
A Malmström, BH Grønberg, C Marosi, R Stupp, D Frappaz, H Schultz, ...
The lancet oncology 13 (9), 916-926, 2012
973*2012
A colorectal cancer classification system that associates cellular phenotype and responses to therapy
A Sadanandam, CA Lyssiotis, K Homicsko, EA Collisson, WJ Gibb, ...
Nature medicine 19 (5), 619-625, 2013
7682013
Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial
R Stupp, S Taillibert, A Kanner, W Read, DM Steinberg, B Lhermitte, ...
Jama 318 (23), 2306-2316, 2017
6512017
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre …
R Stupp, ME Hegi, T Gorlia, SC Erridge, J Perry, YK Hong, KD Aldape, ...
The lancet oncology 15 (10), 1100-1108, 2014
6442014
Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of …
LB Nabors, KL Fink, T Mikkelsen, D Grujicic, R Tarnawski, DH Nam, ...
Neuro-oncology 17 (5), 708-717, 2015
1492015
Nordic Clinical Brain Tumour Study Group (NCBTSG). Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with …
A Malmström, BH Grønberg, C Marosi, R Stupp, D Frappaz, H Schultz, ...
Lancet Oncol 13 (9), 916-926, 2012
1382012
R. European organisation for, T. Treatment of cancer brain, G. Radiotherapy, G. National cancer institute of Canada clinical trials, radiotherapy plus concomitant and adjuvant …
R Stupp, WP Mason, MJ van den Bent, M Weller, B Fisher, MJ Taphoorn, ...
N. Engl. J. Med 352 (10), 987-996, 2005
832005
Mutations in tubulin genes are frequent causes of various foetal malformations of cortical development including microlissencephaly
C Fallet-Bianco, A Laquerrière, K Poirier, F Razavi, F Guimiot, P Dias, ...
Acta neuropathologica communications 2 (1), 1-22, 2014
772014
Phase II study of radiotherapy and temsirolimus versus radiochemotherapy with temozolomide in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation …
W Wick, T Gorlia, P Bady, M Platten, MJ Van Den Bent, MJB Taphoorn, ...
Clinical cancer research 22 (19), 4797-4806, 2016
762016
European Organisation for Research and Treatment of Cancer (EORTC); Canadian Brain Tumor Consortium; CENTRIC study team. Cilengitide combined with standard treatment for …
R Stupp, ME Hegi, T Gorlia, SC Erridge, J Perry, YK Hong, KD Aldape, ...
Lancet Oncol 15 (10), 1100-1108, 2014
672014
Clear Cell Papillary Renal Cell Carcinoma and Renal Angiomyoadenomatous Tumor–Two Variants of a Morphologic, Immunohistochemical and Genetic Distinct Entity of Renal Cell Carcinoma
KF Deml, HU Schildhaus, E Compérat, A von Teichman, M Storz, ...
The American journal of surgical pathology 39 (7), 889, 2015
612015
Phosphorylation of the homeotic tumor suppressor Cdx2 mediates its ubiquitin-dependent proteasome degradation
I Gross, B Lhermitte, C Domon-Dell, I Duluc, E Martin, C Gaiddon, ...
Oncogene 24 (54), 7955-7963, 2005
502005
Methylation of the hTERT promoter: a novel cancer biomarker for leptomeningeal metastasis detection in cerebrospinal fluids
S Bougel, B Lhermitte, G Gallagher, JC de Flaugergues, RC Janzer, ...
Clinical Cancer Research 19 (8), 2216-2223, 2013
492013
Different effects of the Cdx1 and Cdx2 homeobox genes in a murine model of intestinal inflammation
A Calon, I Gross, B Lhermitte, E Martin, F Beck, B Duclos, M Kedinger, ...
Gut 56 (12), 1688-1695, 2007
402007
EORTC 26083 phase I/II trial of dasatinib in combination with CCNU in patients with recurrent glioblastoma
E Franceschi, R Stupp, MJ Van Den Bent, C Van Herpen, ...
Neuro-oncology 14 (12), 1503-1510, 2012
392012
Combination of MRI and dynamic FET PET for initial glioma grading
V Dunet, P Maeder, M Nicod-Lalonde, B Lhermitte, C Pollo, J Bloch, ...
Nuklearmedizin 53 (04), 155-161, 2014
312014
Fragment N2, a caspase‐3‐generated RasGAP fragment, inhibits breast cancer metastatic progression
D Barras, G Lorusso, B Lhermitte, D Viertl, C Rüegg, C Widmann
International journal of cancer 135 (1), 242-247, 2014
242014
Adequately defining tumor cell proportion in tissue samples for molecular testing improves interobserver reproducibility of its assessment
B Lhermitte, C Egele, N Weingertner, D Ambrosetti, B Dadone, V Kubiniek, ...
Virchows Archiv 470 (1), 21-27, 2017
212017
Radiation therapy and concurrent plus adjuvant temsirolimus (CCI-779) versus chemoirradiation with temozolomide in newly diagnosed glioblastoma without methylation of the MGMT …
W Wick, T Gorlia, MJ Van Den Bent, CJ Vecht, J Steuve, AA Brandes, ...
Journal of Clinical Oncology 32 (15_suppl), 2003-2003, 2014
202014
Ex vivo ultrasound control of resection margins during partial nephrectomy
A Doerfler, Y Cerantola, JY Meuwly, B Lhermitte, H Bensadoun, ...
The Journal of urology 186 (6), 2188-2193, 2011
202011
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20